T cells work together to fight cancer (Q33744799)

29 July 2017

1 reference

title

T cells work together to fight cancer (English)

1 reference

29 July 2017

Cerundolo V

1

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 September 1999

1 reference

29 July 2017

1 reference

29 July 2017

volume

9

1 reference

29 July 2017

issue

18

1 reference

29 July 2017

page(s)

R695-7

1 reference

A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2899%2980442-4

7 January 2021

Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2899%2980442-4

7 January 2021

New paths in human cancer serology

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2899%2980442-4

7 January 2021

Cloning genes encoding MHC class II-restricted antigens: mutated CDC27 as a tumor antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2899%2980442-4

7 January 2021

Identification of a novel major histocompatibility complex class II-restricted tumor antigen resulting from a chromosomal rearrangement recognized by CD4(+) T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2899%2980442-4

7 January 2021

Identification of MAGE-3 epitopes presented by HLA-DR molecules to CD4(+) T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2899%2980442-4

7 January 2021

Melanoma cells present a MAGE-3 epitope to CD4(+) cytotoxic T cells in association with histocompatibility leukocyte antigen DR11.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2899%2980442-4

7 January 2021

Biochemical identification of a mutated human melanoma antigen recognized by CD4(+) T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2899%2980442-4

7 January 2021

Vaccination with a recombinant vaccinia virus encoding a "self" antigen induces autoimmune vitiligo and tumor cell destruction in mice: requirement for CD4(+) T lymphocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2899%2980442-4

7 January 2021

Specific T helper cell requirement for optimal induction of cytotoxic T lymphocytes against major histocompatibility complex class II negative tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2899%2980442-4

7 January 2021

Immunology. Licence to kill

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2899%2980442-4

7 January 2021

The central role of CD4(+) T cells in the antitumor immune response

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2899%2980442-4

7 January 2021

Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2899%2980442-4

7 January 2021

Class II MHC molecules can use the endogenous pathway of antigen presentation

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2899%2980442-4

7 January 2021

A receptor for the selective uptake and degradation of proteins by lysosomes

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2899%2980442-4

7 January 2021

Ex vivo staining of metastatic lymph nodes by class I major histocompatibility complex tetramers reveals high numbers of antigen-experienced tumor-specific cytolytic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2899%2980442-4

7 January 2021

10.1016/S0960-9822(99)80442-4

Identifiers

DOI

1 reference

29 July 2017

1 reference